TransCode Therapeutics Inc.

0.43
0.05 (13.16%)
At close: Apr 28, 2025, 3:59 PM
0.42
-2.29%
After-hours: Apr 28, 2025, 07:12 PM EDT

TransCode Therapeutics Stock Forecast

Stock Price Forecast

The 1 analysts with 12-month price forecasts for RNAZ stock have an median target of 10, with a low estimate of 10 and a high estimate of 10. The median target predicts an increase of 2225.58% from the current stock price of 0.43.

Created with Highcharts 11.4.3
Analyst Consensus: Buy
Created with Highcharts 11.4.3May 2024Jul 2024Sep 2024Nov 2024Jan 2025Mar 2025May 2025Jul 2025Sep 2025Nov 2025Jan 2026Mar 2026May 2026May 2…$0$5$10$15

Past 12 Months

12 Month Forecast

Target Low Average Median High
Price $10 $10 $10 $10
Change 2225.58% 2225.58% 2225.58% 2225.58%

Latest Analyst Insight Report

HC Wainwright & Co. has reaffirmed a Buy rating fo... Unlock content with Pro Subscription

Updated Apr 16, 2025

Created with Highcharts 11.4.3May '24Aug '24Sep '24Oct '24Nov '24Dec '24Feb '25Mar '25Apr '250123
Rating Oct 24Nov 24Dec 24Feb 25Mar 25Apr 25
Strong Buy 001000
Buy 110211
Hold 000000
Sell 000000
Strong Sell 000000
Total 1 1 1 2 1 1

Financial Forecast this Year

Revenue This Year
300K
from 0
Increased by -%
Revenue Next Year
1M
from 300K
Increased by 233.3%
EPS This Year
-157.08
from -103.61
Increased by -51.6%
EPS Next Year
-144.21
from -157.08
Increased by 8.2%